Symbols / RGC Stock $22.16 -6.69% Regencell Bioscience Holdings Limited

Healthcare • Drug Manufacturers - Specialty & Generic • Hong Kong • NCM
RGC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Yat-Gai Au
Exch · Country NCM · Hong Kong
Market Cap 10.96B
Enterprise Value 10.96B
Income -7.05M
Sales —
FCF (ttm) —
Book/sh 0.00
Cash/sh 0.01
Employees 10
Insider 10d —
IPO Jul 16, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S —
P/B 11,080.00
P/C —
EV/EBITDA -1,528.24
EV/Sales —
Quick Ratio 1.42
Current Ratio 1.42
Debt/Eq 31.68
LT Debt/Eq —
EPS (ttm) -0.01
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-06-05
Earnings (prior) 2025-11-18
ROA -84.97%
ROE -177.66%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 494.49M
Shs Float 55.41M
Insider Own 88.38%
Instit Own 0.13%
Short Float 1.44%
Short Ratio 7.72
Short Interest 797.14K
52W High 83.60
vs 52W High -73.49%
52W Low 9.39
vs 52W Low 136.00%
Beta —
Impl. Vol. 1.56%
Rel Volume 0.86
Avg Volume 131.42K
Volume 112.75K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $23.75
Price $22.16
Change -6.69%
About

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$22.16
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
$22.16
Low
—
High
—
Mean
—
News
RSS: Latest RGC news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
4.74
-24.50%
6.27
-17.64%
7.62
+451.47%
1.38
Research And Development
1.07
-32.59%
1.58
-37.04%
2.51
+473.13%
0.44
Selling General And Administration
3.67
-21.77%
4.69
-8.10%
5.11
+441.40%
0.94
Selling And Marketing Expense
0.13
-52.25%
0.26
+939.22%
0.03
+1503.74%
0.00
General And Administrative Expense
3.55
-19.96%
4.43
-12.81%
5.08
+439.62%
0.94
Salaries And Wages
—
0.90
-40.00%
1.50
0.00
Other Gand A
3.55
-19.96%
4.43
-12.81%
5.08
+439.62%
0.94
Total Expenses
4.74
-24.50%
6.27
-17.64%
7.62
+451.47%
1.38
Operating Income
-4.74
+24.50%
-6.27
+17.64%
-7.62
-451.47%
-1.38
Total Operating Income As Reported
-4.74
+24.50%
-6.27
+17.64%
-7.62
-451.47%
-1.38
EBITDA
-3.99
+27.49%
-5.50
+21.52%
-7.01
-417.63%
-1.35
Normalized EBITDA
-3.99
+27.49%
-5.50
+21.52%
-7.01
-417.63%
-1.35
Reconciled Depreciation
0.75
-3.13%
0.77
+27.35%
0.60
+2184.54%
0.03
EBIT
-4.74
+24.50%
-6.27
+17.64%
-7.62
-451.47%
-1.38
Net Income
-4.30
+26.73%
-5.87
+21.15%
-7.45
-452.88%
-1.35
Pretax Income
-4.36
+28.03%
-6.06
+20.18%
-7.59
-463.92%
-1.35
Other Income Expense
0.37
+76.73%
0.21
+810.37%
0.02
-32.94%
0.03
Other Non Operating Income Expenses
0.37
+76.73%
0.21
+810.37%
0.02
-32.94%
0.03
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-4.36
+28.03%
-6.06
+20.18%
-7.59
-463.92%
-1.35
Net Income From Continuing Operation Net Minority Interest
-4.30
+26.73%
-5.87
+21.15%
-7.45
-452.88%
-1.35
Net Income From Continuing And Discontinued Operation
-4.30
+26.73%
-5.87
+21.15%
-7.45
-452.88%
-1.35
Net Income Continuous Operations
-4.36
+28.03%
-6.06
+20.18%
-7.59
-463.92%
-1.35
Minority Interests
0.06
-67.90%
0.19
+28.66%
0.15
0.00
Normalized Income
-4.30
+26.73%
-5.87
+21.15%
-7.45
-452.88%
-1.35
Net Income Common Stockholders
-4.30
+26.73%
-5.87
+21.15%
-7.45
-452.88%
-1.35
Diluted EPS
-0.01
+26.89%
-0.01
+22.03%
-0.02
—
Basic EPS
-0.01
+26.89%
-0.01
+22.03%
-0.02
—
Basic Average Shares
494.49
+0.00%
494.49
+1.62%
486.62
—
Diluted Average Shares
494.49
+0.00%
494.49
+1.62%
486.62
—
Diluted NI Availto Com Stockholders
-4.30
+26.73%
-5.87
+21.15%
-7.45
-452.88%
-1.35
Line Item Trend 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total Assets
8.44
-33.15%
12.62
-29.95%
18.02
+5197.59%
0.34
Current Assets
8.11
-30.18%
11.62
-29.33%
16.44
+24499.61%
0.07
Cash Cash Equivalents And Short Term Investments
7.96
-31.16%
11.56
-29.56%
16.42
+27532.00%
0.06
Cash And Cash Equivalents
2.96
+89.24%
1.56
-75.61%
6.42
+10700.66%
0.06
Cash Financial
2.96
+89.24%
1.56
-75.61%
6.42
+10700.66%
0.06
Other Short Term Investments
5.00
-50.00%
10.00
+0.00%
10.00
0.00
Receivables
0.15
+170.17%
0.06
+104.90%
0.03
+271.14%
0.01
Other Receivables
0.15
+170.17%
0.06
+104.90%
0.03
+271.14%
0.01
Prepaid Assets
—
—
0.03
+271.14%
0.01
Total Non Current Assets
0.32
-67.59%
1.00
-36.45%
1.57
+476.07%
0.27
Net PPE
0.23
-74.60%
0.89
-38.91%
1.46
+1683.45%
0.08
Gross PPE
1.01
-26.12%
1.37
-16.89%
1.65
+1296.96%
0.12
Accumulated Depreciation
-0.78
-64.68%
-0.48
-155.84%
-0.19
-417.40%
-0.04
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.30
+2.21%
0.30
-0.54%
0.30
0.00
Other Properties
0.08
-81.21%
0.45
-39.65%
0.75
—
Leases
0.62
+0.38%
0.62
+3.31%
0.60
+410.47%
0.12
Non Current Deferred Assets
—
—
0.00
-100.00%
0.17
Non Current Prepaid Assets
0.10
-9.97%
0.11
-5.08%
0.11
+498.25%
0.02
Total Liabilities Net Minority Interest
0.22
-65.28%
0.63
-32.59%
0.94
-78.38%
4.34
Current Liabilities
0.19
-68.10%
0.61
+5.05%
0.58
-86.68%
4.34
Payables And Accrued Expenses
0.13
-20.68%
0.17
+1.12%
0.17
-74.57%
0.66
Payables
0.01
-20.12%
0.01
-32.46%
0.02
-81.10%
0.08
Current Accrued Expenses
0.13
-20.72%
0.16
+4.60%
0.15
-73.62%
0.57
Current Debt And Capital Lease Obligation
0.06
-86.35%
0.44
+6.64%
0.41
-88.84%
3.68
Current Debt
—
—
—
3.68
Other Current Borrowings
—
—
—
3.68
Current Capital Lease Obligation
0.06
-86.35%
0.44
+6.64%
0.41
0.00
Total Non Current Liabilities Net Minority Interest
0.03
+2.08%
0.03
-92.95%
0.36
0.00
Long Term Debt And Capital Lease Obligation
0.03
+2.08%
0.03
-92.95%
0.36
0.00
Long Term Capital Lease Obligation
0.03
+2.08%
0.03
-92.95%
0.36
0.00
Stockholders Equity
8.22
-31.68%
12.03
-29.50%
17.07
+526.89%
-4.00
Common Stock Equity
8.22
-31.68%
12.03
-29.50%
17.07
+526.89%
-4.00
Capital Stock
0.00
+0.00%
0.00
+0.00%
0.00
+30.00%
0.00
Common Stock
0.00
+0.00%
0.00
+0.00%
0.00
+30.00%
0.00
Share Issued
494.49
+0.00%
494.49
+0.00%
494.49
+2.93%
480.40
Ordinary Shares Number
494.49
+0.00%
494.49
+0.00%
494.49
+2.93%
480.40
Additional Paid In Capital
29.88
+1.53%
29.43
+3.24%
28.51
+11136346.88%
0.00
Retained Earnings
-21.62
-24.84%
-17.32
-51.30%
-11.44
-186.24%
-4.00
Gains Losses Not Affecting Retained Earnings
-0.05
+47.19%
-0.09
0.00
—
Minority Interest
0.00
+100.00%
-0.04
-365.78%
0.02
0.00
Other Equity Adjustments
-0.05
+47.19%
-0.09
—
—
Total Equity Gross Minority Interest
8.22
-31.45%
11.99
-29.81%
17.08
+527.27%
-4.00
Total Capitalization
8.22
-31.68%
12.03
-29.50%
17.07
+526.89%
-4.00
Working Capital
7.92
-28.09%
11.01
-30.58%
15.87
+471.51%
-4.27
Invested Capital
8.22
-31.68%
12.03
-29.50%
17.07
+5506.15%
-0.32
Total Debt
0.09
-81.51%
0.46
-39.88%
0.77
-79.05%
3.68
Net Debt
—
—
—
3.62
Capital Lease Obligations
0.09
-81.51%
0.46
-39.88%
0.77
0.00
Net Tangible Assets
8.22
-31.68%
12.03
-29.50%
17.07
+526.89%
-4.00
Tangible Book Value
8.22
-31.68%
12.03
-29.50%
17.07
+526.89%
-4.00
Dueto Related Parties Current
0.01
-20.12%
0.01
-32.46%
0.02
-81.10%
0.08
Line Item Trend 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Operating Cash Flow
-4.00
+19.37%
-4.96
+5.77%
-5.27
-586.43%
-0.77
Cash Flow From Continuing Operating Activities
-4.00
+19.37%
-4.96
+5.77%
-5.27
-586.43%
-0.77
Net Income From Continuing Operations
-4.36
+28.03%
-6.06
+20.18%
-7.59
-463.92%
-1.35
Depreciation Amortization Depletion
0.75
-3.13%
0.77
+27.35%
0.60
+2184.54%
0.03
Depreciation
0.75
-3.13%
0.77
+27.35%
0.60
+2184.54%
0.03
Depreciation And Amortization
0.75
-3.13%
0.77
+27.35%
0.60
+2184.54%
0.03
Other Non Cash Items
-0.25
-190.40%
-0.09
-695.68%
-0.01
—
Stock Based Compensation
0.45
-51.30%
0.92
-66.55%
2.76
0.00
Operating Gains Losses
—
0.00
—
—
Gain Loss On Sale Of PPE
0.00
-100.00%
0.00
0.00
0.00
Change In Working Capital
-0.59
-15.02%
-0.51
+50.30%
-1.02
-285.19%
0.55
Change In Prepaid Assets
-0.09
-269.01%
-0.02
+77.88%
-0.10
-1237.23%
-0.01
Change In Payables And Accrued Expense
-0.03
-1961.26%
0.00
+100.38%
-0.49
-187.20%
0.56
Change In Accrued Expense
-0.03
-571.00%
0.01
+101.65%
-0.42
-188.26%
0.48
Change In Payable
-0.00
+58.13%
-0.01
+92.44%
-0.07
-181.10%
0.08
Change In Other Current Liabilities
-0.47
+4.63%
-0.49
-13.30%
-0.43
0.00
Investing Cash Flow
5.24
+8789.12%
0.06
+100.55%
-10.78
0.00
Cash Flow From Continuing Investing Activities
5.24
+8789.12%
0.06
+100.55%
-10.78
0.00
Net PPE Purchase And Sale
-0.01
+79.65%
-0.03
+96.62%
-0.78
0.00
Purchase Of PPE
-0.01
+80.37%
-0.03
+96.49%
-0.78
0.00
Sale Of PPE
0.00
-100.00%
0.00
0.00
0.00
Capital Expenditure
-0.01
+80.37%
-0.03
+96.49%
-0.78
—
Net Investment Purchase And Sale
5.25
+6045.20%
0.09
+100.85%
-10.00
0.00
Purchase Of Investment
-5.00
+50.00%
-10.00
+0.00%
-10.00
0.00
Sale Of Investment
10.25
+1.61%
10.09
0.00
0.00
Financing Cash Flow
0.10
-24.19%
0.13
-99.40%
22.41
+4995.12%
0.44
Cash Flow From Continuing Financing Activities
0.10
-24.19%
0.13
-99.40%
22.41
+4995.12%
0.44
Net Issuance Payments Of Debt
0.00
0.00
+100.00%
-0.43
-170.58%
0.61
Issuance Of Debt
—
—
—
0.61
Short Term Debt Issuance
—
—
—
0.61
Net Short Term Debt Issuance
0.00
0.00
+100.00%
-0.43
-170.58%
0.61
Net Common Stock Issuance
0.00
0.00
-100.00%
22.67
0.00
Net Other Financing Charges
0.10
-24.19%
0.13
-17.74%
0.16
+195.18%
-0.17
Changes In Cash
1.34
+128.17%
-4.77
-175.01%
6.36
+2040.86%
-0.33
Effect Of Exchange Rate Changes
0.05
+164.01%
-0.08
0.00
0.00
Beginning Cash Position
1.56
-75.61%
6.42
+10700.66%
0.06
-84.65%
0.39
End Cash Position
2.96
+89.24%
1.56
-75.61%
6.42
+10700.66%
0.06
Free Cash Flow
-4.01
+19.70%
-4.99
+17.49%
-6.05
-688.20%
-0.77
Interest Paid Supplemental Data
0.00
0.00
0.00
0.00
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Common Stock Issuance
0.00
0.00
-100.00%
22.67
0.00
Issuance Of Capital Stock
0.00
0.00
-100.00%
22.67
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category